Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 15 de 15
Filtrer
1.
Stem Cells ; 13 Suppl 2: 160-3, 1995 Aug.
Article de Anglais | MEDLINE | ID: mdl-8520506

RÉSUMÉ

The aim of the study was to evaluate the feasibility and the efficacy of high-dose chemoradiotherapy followed by autologous hematopoietic stem cell support with peripheral blood progenitor cells (PBPC) harvested after high-dose cyclophosphamide (HDCYC) treatment in patients with high-risk multiple myeloma (MM). Inclusion criteria were: age less than 65 years and high-risk MM defined as stage II MM, stage III MM, refractory or relapsed MM. The design of the study was: 1) HDCYC +/- hematopoietic growth factors followed by PBPC collection, and 2) high-dose melphalan combined with total body irradiation (or busulfan for previously irradiated patients) followed by PBPC reinfusion (ABPCT). All 60 patients completed the procedure except two who died from infection after HDCYC and another of acute cardiac failure after reinfusion of PBPC. Out of the 60 evaluable patients, three failed to respond while the other 57 achieved either a partial (n = 33) or complete (n = 24) response. Thirty-one patients progressed or relapsed after a median duration of response of 15 months (range: 3-43). The median follow-up for the other 26 responder patients was 24 months (range: 2-66). Twenty-one patients died, 18 of MM (2 after failure, 16 after relapse) and three responders of lung cancer (n = 1) and infection (n = 2). In conclusion, this study shows that this therapeutic approach is feasible and efficient.


Sujet(s)
Transplantation de cellules souches hématopoïétiques , Myélome multiple/thérapie , Adulte , Sujet âgé , Association thérapeutique , Cyclophosphamide/administration et posologie , Femelle , Facteurs de croissance hématopoïétique/administration et posologie , Humains , Mâle , Melphalan/administration et posologie , Adulte d'âge moyen , Myélome multiple/traitement médicamenteux , Myélome multiple/radiothérapie , Facteurs de risque , Analyse de survie , Transplantation autologue , Irradiation corporelle totale
2.
Planet Space Sci ; 43(1-2): 129-37, 1995.
Article de Anglais | MEDLINE | ID: mdl-11538426

RÉSUMÉ

Secondary ion mass spectrometry is a powerful analytical tool, which has the potentiality, through molecular ion emission, of detecting minor phases, as well as the unique capability of directly measuring isotope abundances in mineral or organic phases without any prior physical, chemical or thermal processing. Applied to the in situ analysis of the Martian regolith, it can provide evidence of the presence of carbonates and, by inference (if carbonates constitute significant deposits), of past liquid water--a necessary condition for the development of life. In addition, oxygen isotopic composition of carbonates preserves a record of the temperature at which this phase precipitated and may therefore help decipher the past climatology of Mars. Detection of a carbon isotopic composition shift between carbonates and organic matter (on Earth, the result of a kinetic fractionation effect during photosynthesis) would provide a definite clue regarding the existence of a past biochemical activity on Mars.


Sujet(s)
Mars , Spectrométrie de masse/méthodes , Sol/analyse , Isotopes du carbone , Carbonates/analyse , Climat , Exobiologie , Phénomènes géologiques , Géologie , Origine de la vie , Oxygène/analyse , Isotopes de l'oxygène , Silicates/analyse , Température , Eau/analyse
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...